Nath Bio-Genes shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health51/100
Valuation
100/100 · PB 0.5041
Technical
Avoid
1M 1.468%
6M 10.355%
1Y -17.516%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present